Letter: COVID-19 outcomes and anti-TNF treatments-comprehensive evidence matters. Authors' reply.

Kokkotis, Georgios; Kitsou, Konstantina; Bamias, Giorgos

Kokkotis, Georgios; Kitsou, Konstantina; Bamias, Giorgos.

Kokkotis G; GI Unit, 3rd Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Kitsou K; Immunobiology and Vaccinology Research Lab, First Department of Paediatrics, "Aghia Sophia" Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Bamias G; GI Unit, 3rd Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Aliment Pharmacol Ther ; 55(9): 1235-1236, 2022 05.

Article in English | MEDLINE | ID: covidwho-1794752

Subject(s)

COVID-19; Crohn Disease; Inflammatory Bowel Diseases; Humans; Tumor Necrosis Factor Inhibitors

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Crohn Disease / COVID-19 Limits: Humans Language: English Journal: Aliment Pharmacol Ther Journal subject: Pharmacology / Gastroenterology / Drug Therapy Year: 2022 Document Type: Article Affiliation country: Apt.16904

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google